Gilead and Arcus Announce Amended Collaboration and Equity Investment : vimarsana.com

Gilead Sciences, Inc. (Nasdaq: GILD) and Arcus Biosciences, Inc. (NYSE: RCUS) today announced an amendment to their collaboration agreement and a separate equity investment by Gilead of $320 million in Arcus common stock at $21.00 per share. The equity investment and collaboration amendment enable accelerated ...

Related Keywords

China , California , United States , Foster City , Terry Rosen , Merdad Parsey , Johanna Mercier , Guangzhou Gloria Biosciences Co , Nasdaq , Exchange Commission , Arcus Biosciences Inc , Gilead Sciences Inc , Astrazeneca , Gilead Sciences , Investment Reinforces Companie Conviction , Provides Opportunity , Equity Investment , Raising Gilead , Ownership Stake , Provides Gilead , One Additional Seat , Arcus Biosciences , Chief Commercial Officer , Arcus Board , Chief Medical Officer , Chief Executive Officer , Gloria Biosciences , Arcus Bioscience , Private Securities Litigation Reform Act , Quarterly Report ,